These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 5545268

  • 1. The effect of L-asparaginase on mitotic activity during N-2-fluorenylacetamide hepatocarcinogenesis: subpopulations of nodular cells.
    Becker FF, Klein KM.
    Cancer Res; 1971 Feb; 31(2):169-73. PubMed ID: 5545268
    [No Abstract] [Full Text] [Related]

  • 2. Combined enzyme histochemical and radioautographic studies on areas of hyperplasia in the liver of rats fed N-2-fluorenylacetamide.
    Kitagawa T, Sugano H.
    Cancer Res; 1973 Nov; 33(11):2993-3001. PubMed ID: 4355988
    [No Abstract] [Full Text] [Related]

  • 3. Mitotic, chromosomal, and nucleolar alterations induced by thioacetamide in relation to the mitotic cycle after partial hepatectomy.
    Mironescu S, Clovîrnache M.
    J Natl Cancer Inst; 1971 Jan; 46(1):49-61. PubMed ID: 4100558
    [No Abstract] [Full Text] [Related]

  • 4. The synergistic effect of hypoglycemia and L-asparaginase upon transplantable hepatomas of varying growth rates.
    Becker FF, Klein KM.
    Cancer Res; 1972 Oct; 32(10):2082-4. PubMed ID: 4343006
    [No Abstract] [Full Text] [Related]

  • 5. Effect of L-asparaginase on DNA synthesis in regenerating liver and in other dividing tissues.
    Becker FF, Baserga R, Broome JD.
    Cancer Res; 1970 Jan; 30(1):133-7. PubMed ID: 5458958
    [No Abstract] [Full Text] [Related]

  • 6. Cellular analysis of liver carcinogenesis. 3. Comparison of the ultrastructure of hyperplastic liver nodules and hepatocellular carcinomas induced in rat liver by 2-fluorenylacetamide.
    Merkow LP, Epstein SM, Farber E, Pardo M, Bartus B.
    J Natl Cancer Inst; 1969 Jul; 43(1):33-63. PubMed ID: 4307705
    [No Abstract] [Full Text] [Related]

  • 7. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene.
    Peraino C, Fry RJ, Staffeldt E.
    Cancer Res; 1971 Oct; 31(10):1506-12. PubMed ID: 4328739
    [No Abstract] [Full Text] [Related]

  • 8. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL, Becker FF.
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract] [Full Text] [Related]

  • 9. Increased selectivity of interaction between fluorenylamine carcinogens and liver proteins during hepatocarcinogenesis.
    Sorof S, Young EM, McBride RZ, Coffey CB, Luongo L.
    Mol Pharmacol; 1969 Nov; 5(6):625-39. PubMed ID: 5373894
    [No Abstract] [Full Text] [Related]

  • 10. Influence of orotic acid on liver tumorigenesis in rats ingesting ethionine, N-2-fluorenylacetamide, and 3'-methyl-dimethylaminoazobenzene.
    Sidransky H, Verney E.
    J Natl Cancer Inst; 1970 May; 44(5):1201-15. PubMed ID: 5514477
    [No Abstract] [Full Text] [Related]

  • 11. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis.
    Becker FF, Fox RA, Klein KM, Wolman SR.
    J Natl Cancer Inst; 1971 Jun; 46(6):1261-9. PubMed ID: 4325934
    [No Abstract] [Full Text] [Related]

  • 12. Combination of enzyme histochemistry and radioautography: a new method applied to analysis of hepatocarcinogenesis.
    Kitagawa T, Sugano H.
    Gan; 1972 Aug; 63(4):509. PubMed ID: 5081629
    [No Abstract] [Full Text] [Related]

  • 13. Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.
    Witschi H, Epstein SM, Farber E.
    Cancer Res; 1971 Mar; 31(3):270-3. PubMed ID: 5547215
    [No Abstract] [Full Text] [Related]

  • 14. Early elevation of alpha 1-fetoprotein in N-2-fluorenylacetamide hepatocarcinogenesis.
    Becker FF, Sell S.
    Cancer Res; 1974 Oct; 34(10):2489-94. PubMed ID: 4412886
    [No Abstract] [Full Text] [Related]

  • 15. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction.
    Albert RE, Burns FJ, Bilger L, Gardner D, Troll W.
    Cancer Res; 1972 Oct; 32(10):2172-7. PubMed ID: 4343011
    [No Abstract] [Full Text] [Related]

  • 16. Effects of 2-acetylaminofluorene on liver cell proliferation after partial hepatectomy of female rats.
    Jackson CD, Irving CC.
    Cancer Res; 1973 Feb; 33(2):397-401. PubMed ID: 4688886
    [No Abstract] [Full Text] [Related]

  • 17. Mitotic blockage at G2 after partial hepatectomy during 4-dimethylaminoazobenzene hepatocarcinogenesis.
    Banerjee MR.
    J Natl Cancer Inst; 1965 Oct; 35(4):585-9. PubMed ID: 4953914
    [No Abstract] [Full Text] [Related]

  • 18. Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism.
    Epstein S, Ito N, Merkow L, Farber E.
    Cancer Res; 1967 Sep; 27(9):1702-11. PubMed ID: 4293077
    [No Abstract] [Full Text] [Related]

  • 19. Effect of p-hydroxyacetanilide on liver cancer induction by N hydroxy-N-2-fluorenylacetamide.
    Yamamoto RS, Williams GM, Richardson HL, Weisburger EK, Weisburger JH.
    Cancer Res; 1973 Mar; 33(3):454-7. PubMed ID: 4347712
    [No Abstract] [Full Text] [Related]

  • 20. Liver regeneration and induction of hepatomas in B6AF mice by urethan.
    Chernozemski IN, Warwick GP.
    Cancer Res; 1970 Nov; 30(11):2685-90. PubMed ID: 4321085
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.